Navigation Links
Hawaii's Premier Physician Management Company, TeamPraxis, Selects Allscripts Electronic Health Record for Statewide Deployment
Date:3/12/2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2008)...linical trial results could lead to availability o...eatment for deep lines and wrinkles by 2009. , ... 24, 2008 -- Gel-Del Technologies , a St. Paul, M... that it has concluded clinical trials of CosmetaL...als say holds potential to be a more effective alt...
(Date:7/24/2008)...ll/ --, Key Highlights, Misys plc (LSE: MSY) del...sing targets for the next phase of the turnaround....%, bringing Group operating profit(2) to GBP81m,3...trategy and entering,into the next phase of the tu...o view the Multimedia News Release, please click:,...
(Date:7/23/2008)...wire/ -- MediVoice(R), LLC, the,world,s first mobi...escribing, has formed a strategic partnership with... web-based, patient-centered health record,managem...e and market its,mobile voice-activation solution ...., "MediVoice is pleased to develop a strategic p...
(Date:7/23/2008)..., July 23 /PRNewswire-FirstCall/ - Cardiome Pharma...t it has entered into an,agreement with CR Intrins...,CR Intrinsic Investors, LLC, an affiliate of S.A....ertible preferred shares for gross proceeds of,US$... for general corporate,purposes, costs associated ...
Breaking Medicine News(10 mins):Health News:Clinical Trial Concluded For New Wrinkle Treatment 2Health News:Clinical Trial Concluded For New Wrinkle Treatment 3Health News:Misys Announces Preliminary Results for the Year Ended 31 May 2008 2Health News:Misys Announces Preliminary Results for the Year Ended 31 May 2008 3Health News:Misys Announces Preliminary Results for the Year Ended 31 May 2008 4Health News:MediVoice(R) Partners With VisionTree(R) to Integrate Its Voice-Activated e-Prescribing Solution Into VisionTree's VTOC(TM) Web-Based Patient Management System 2Health News:MediVoice(R) Partners With VisionTree(R) to Integrate Its Voice-Activated e-Prescribing Solution Into VisionTree's VTOC(TM) Web-Based Patient Management System 3Health News:Cardiome Announces Preferred Share Financing 2Health News:Cardiome Announces Preferred Share Financing 3
...University of California Board of Regents today ap...million toward the development of the first phase...lanning to build a 289-bed, integrated medical cen...cer patients on a 14.5-acre parcel, which is south...
...heme educating coaches and referees in the dangers...duction in the number of spinal injuries suffered ...is weeks BMJ. Spinal cord injuries, although rar... permanently disabling injuries and death in rugby...
...ntists from Australia and UK writing in the Lancet...p cut down the risks of mothers-to-be developing ...s of 31 trials involving more than 32,000 women fo...protective effect of this drug against pre-eclamps...
...ntists at the University of Virginia and the Medic...e that participates in the regulation of the body...n regulating metabolism. Their finding shows that...ich is regulated by the circadian clock in the org...
Other Medicine News:Health News:UC Regents Approve Fundraised Campaign for UCSF Medical Center at Mission Bay 2Health News:Innovative Education Scheme Sees Fewer Rugby Players Suffering Spinal Injuries 2Health News:Research Favors Aspirin In Prevention Of Pre-Eclampsia 2Health News:Clock Gene Plays Role in Weight Gain, Study Finds 2
(Date:7/22/2008)...y Demonstrates Feasibility and Efficacy of Treatin...iver Cancer, SAN FRANCISCO, and YONGIN-SI, South ... Francisco, CA and Ottawa, Ontario), and its South... that novel findings from,a Phase I clinical trial...rated that the product was well-tolerated and resu...
(Date:7/22/2008)...TH SAN FRANCISCO, Calif., July 22 /- ...t has completed patient enrollment,in its Phase 1/...ity and,ammonia scavenging effects of HPN-100 (for...ylbutyrate) in patients with urea cycle disorders,...lts in the fourth quarter,of this year., (Logo: ...
(Date:7/22/2008)...HIA ANTIPOLIS, France, July 22 /PRNewswire-FirstCa...unced it has successfully completed the,enrollment...ed hypertension,in two clinical pharmacology studi...nnounced timelines. These trials are designed to a...n comparison to ibuprofen and,naproxen, using the ...
(Date:7/21/2008)... YORK, July 21 /- Ari Kiev, M.D., pre... speaker at the upcoming conference Wall,Street Un...ement,s Guide to,Wall Street. The conference will ...errace, 267 Fifth Avenue in New York. The event is...d mid-cap life science companies to gain,better in...
Breaking Medicine Technology:Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 2Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 4Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 2Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 3NicOx Completes Enrollment of Two Ambulatory Blood Pressure Measurement (ABPM) Studies for Naproxcinod in Hypertensive OA Patients 2NicOx Completes Enrollment of Two Ambulatory Blood Pressure Measurement (ABPM) Studies for Naproxcinod in Hypertensive OA Patients 3Coherent Inc to Webcast First Fiscal Quarter 2008 Results 9937 1Dave Perbix Named Vice President Occupational Health Sales and Marketing for Kaiser Permanente 9933 1Dave Perbix Named Vice President Occupational Health Sales and Marketing for Kaiser Permanente 9933 2Vapotherm 28R 29 Announces Validation of U S Patent 2694 1Vapotherm 28R 29 Announces Validation of U S Patent 2694 2Clinimetrics Celebrates 20th Anniversary in Contract Research Business 2690 1
...FirstCall/ -- Vical,Incorporated today announced t...d positive results following interim analysis of d... 3 trial of an,angiogenesis product candidate usin...ndings that the primary efficacy,endpoint in the t...ce and that there were no major safety concerns re...
...AMADEO, one of the,first studies to compare the p...ockers in hypertensive patients with,diabetic nep...f Hypertension, Milan. The results from this study...ignificantly greater extent,than losartan.(1) ...ss, Foothills Hospital,in Calgary, Canada said "T...
Other Medicine Technology:Vical Licensee AnGes MG Announces Positive Results of Phase 3,Angiogenesis Trial in Japan 2Vical Licensee AnGes MG Announces Positive Results of Phase 3,Angiogenesis Trial in Japan 3Vical Licensee AnGes MG Announces Positive Results of Phase 3,Angiogenesis Trial in Japan 4Vical Licensee AnGes MG Announces Positive Results of Phase 3,Angiogenesis Trial in Japan 5New Study Shows That telmisartan has Greater Renoprotective,Potential Thanlosartan in Hypertensive Patients With Type 2,Diabetes 2New Study Shows That telmisartan has Greater Renoprotective,Potential Thanlosartan in Hypertensive Patients With Type 2,Diabetes 3New Study Shows That telmisartan has Greater Renoprotective,Potential Thanlosartan in Hypertensive Patients With Type 2,Diabetes 4New Study Shows That telmisartan has Greater Renoprotective,Potential Thanlosartan in Hypertensive Patients With Type 2,Diabetes 5
Anti Gliadin IgA Enzyme Immunosay for quantitative determination of Gliadin-IgG antibodies in serum.
...igned as a high throughput primary or backup instr...r offers performance and reliability equal to or g...advanced technology of the AUTION JET AJ-4270 and ...ate results, limiting interference from elevated p...
Assay uses highly specific rabbit anti-estriol antibody reparation - negligible cross-reactivity with other estrogen metabolites. Excellent assay precision and reproducibility. Superior sensitivity
...rone Sulfate (E1S) is the most abundant circulatin... men [1,2]. Estrone Sulfate is a major metabolite ...fe in blood [2,3]. In premenopausal women, estrone...e and estradiol, rising gradually during the folli...
Medicine Products: